Drug Makers Spotlight ‘Superbug’ Threat In Call For Government To Act
More than 80 companies will release a declaration at the World Economic Forum on Thursday calling for new economic models and help from countries' governments to cut down on the unnecessary antibiotic use and encourage the development of new medicines.
The New York Times:
To Fight ‘Superbugs,’ Drug Makers Call For Incentives To Develop Antibiotics
More than 80 pharmaceutical and diagnostic companies from around the world are calling for new economic models to spur development of badly needed new antibiotics and to fight the rising global threat of drug-resistant “superbugs.” In a declaration that is being released on Thursday at the World Economic Forum in Davos, Switzerland, the companies say that governments must work with companies to fight the problem of antimicrobial resistance. (Pollack, 1/20)
The Wall Street Journal:
Drug And Diagnostic Companies Issue Joint Declaration On Antibiotics
More than 80 drug and diagnostic companies have committed to working together to develop new antibiotics, while calling on governments to improve the financial incentives for doing so, in a declaration released at the World Economic Forum in Davos, Switzerland. The group, which includes pharmaceutical giants such as Johnson & Johnson, Novartis AG, Roche Holding AG and Pfizer Inc., said combating a “dramatic” increase in drug-resistant bacteria required governments to create market incentives for developing new antibiotics and diagnostic tools. (Roland, 1/20)